Project Notice |
|
| PNR | 40288 |
| Project Name | PEPTICHIP: Streamlined identification of tumour neoantigens for personalised anti-cancer immunotherapy |
| Project Detail | The key to unlock your immune response to cancer may be on the horizon Cancer immunotherapy harnesses a persons immune system to fight cancer either by stimulating the patients own immune system or by providing man-made immune system components. It was voted breakthrough of the year’ by Science magazine in 2013. However, despite its potential, patient response rates vary and often only a small portion respond favourably to a given treatment. Personalised cancer immunotherapy could unlock the potential but current methods are expensive and time-consuming. PeptiCHIP has developed a system to identify and purify patient-specific neoantigens (newly formed antigens that have not been previously recognised by the immune system) quickly and easily. EU funding is helping partners establish the business to make it available to millions of patients worldwide. |
| Funded By | European Union (EU) |
| Sector | Electronics |
| Country | Finland , Western Europe |
| Project Value | Plz Refer Document |
Contact Information |
|
| Company Name | HELSINGIN YLIOPISTO |
| Address | Yliopistonkatu 3 00014 Helsingin Yliopisto |
| Web Site | https://cordis.europa.eu/project/id/861947 |
